Gabriel Cabot

4.7k total citations
57 papers, 3.1k citations indexed

About

Gabriel Cabot is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Gabriel Cabot has authored 57 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Medicine, 35 papers in Molecular Biology and 19 papers in Pharmacology. Recurrent topics in Gabriel Cabot's work include Antibiotic Resistance in Bacteria (50 papers), Bacterial biofilms and quorum sensing (30 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Gabriel Cabot is often cited by papers focused on Antibiotic Resistance in Bacteria (50 papers), Bacterial biofilms and quorum sensing (30 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Gabriel Cabot collaborates with scholars based in Spain, Canada and Sweden. Gabriel Cabot's co-authors include Antonio Oliver, Carlos Juan, Bartolomé Moyá, Laura Zamorano, Antonio Oliver, Xavier Mulet, Carla López-Causapé, Alain A. Ocampo-Sosa, Carmen Peña and Luis Martínez‐Martínez and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Gabriel Cabot

57 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Gabriel Cabot	2.6k	1.4k	957	564	523	57	3.1k
Laura Zamorano	2.3k 0.9×	1.2k 0.8×	935 1.0×	457 0.8×	549 1.0×	67	2.9k
Bartolomé Moyá	2.7k 1.0×	1.3k 0.9×	1.1k 1.1×	446 0.8×	657 1.3×	51	3.2k
Antonio Oliver	1.8k 0.7×	973 0.7×	655 0.7×	359 0.6×	386 0.7×	39	2.2k
Katy Jeannot	1.9k 0.7×	1.1k 0.7×	555 0.6×	255 0.5×	486 0.9×	73	2.4k
Philip Lister	1.7k 0.6×	985 0.7×	853 0.9×	368 0.7×	306 0.6×	50	2.6k
Ørjan Samuelsen	3.1k 1.2×	1.1k 0.8×	765 0.8×	434 0.8×	1.4k 2.7×	95	4.0k
Xavier Mulet	1.6k 0.6×	890 0.6×	620 0.6×	437 0.8×	349 0.7×	34	1.9k
Kalyan D. Chavda	2.5k 1.0×	657 0.5×	769 0.8×	265 0.5×	1.0k 2.0×	45	2.9k
Carla López-Causapé	1.6k 0.6×	982 0.7×	445 0.5×	356 0.6×	281 0.5×	69	2.0k
Xiaoting Hua	1.7k 0.7×	876 0.6×	395 0.4×	164 0.3×	709 1.4×	138	2.6k

Countries citing papers authored by Gabriel Cabot

Since Specialization

Citations

This map shows the geographic impact of Gabriel Cabot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriel Cabot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriel Cabot more than expected).

Fields of papers citing papers by Gabriel Cabot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriel Cabot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriel Cabot. The network helps show where Gabriel Cabot may publish in the future.

Co-authorship network of co-authors of Gabriel Cabot

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriel Cabot. A scholar is included among the top collaborators of Gabriel Cabot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriel Cabot. Gabriel Cabot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martı́n, Luisa, Marcus Höring, Gerhard Liebisch, et al.. (2024). Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism. mBio. 15(10). e0134724–e0134724. 3 indexed citations

Barceló, Isabel M., Estrella Rojo‐Molinero, Elena Jordana‐Lluch, et al.. (2024). In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants. Microbiology Spectrum. 12(4). e0035824–e0035824. 2 indexed citations

Cabot, Gabriel, et al.. (2024). Differential contribution of PBP occupancy and efflux on the effectiveness of β-lactams at their target site in clinical isolates of Neisseria gonorrhoeae. PLoS Pathogens. 20(12). e1012783–e1012783. 1 indexed citations

Barceló, Isabel M., Gabriel Cabot, Elena Jordana‐Lluch, et al.. (2024). Transferable AmpCs in Klebsiella pneumoniae : interplay with peptidoglycan recycling, mechanisms of hyperproduction, and virulence implications. Antimicrobial Agents and Chemotherapy. 68(5). e0131523–e0131523. 2 indexed citations

Lasarte-Monterrubio, Cristina, Pablo A. Fraile-Ribot, Juan Carlos Vázquez-Ucha, et al.. (2022). Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 77(10). 2809–2815. 42 indexed citations

Gomis-Font, María A., Gabriel Cabot, Laura Zamorano, et al.. (2021). Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones. Journal of Antimicrobial Chemotherapy. 77(4). 957–968. 21 indexed citations

Barceló, Isabel M., Gabriel Cabot, Prashant Joshi, et al.. (2021). In vitroevolution of cefepime/zidebactam (WCK 5222) resistance inPseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact onin vivoefficacy. Journal of Antimicrobial Chemotherapy. 76(10). 2546–2557. 23 indexed citations

Khaledi, Ariane, Aaron Weimann, Monika Schniederjans, et al.. (2020). Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics. EMBO Molecular Medicine. 12(3). e10264–e10264. 127 indexed citations

Moyá, Bartolomé, Sachin Bhagwat, Gabriel Cabot, et al.. (2020). Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 75(6). 1474–1478. 40 indexed citations

10.

Arca-Suárez, Jorge, Cristina Lasarte-Monterrubio, Gabriel Cabot, et al.. (2020). Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDRPseudomonas aeruginosainfections. Journal of Antimicrobial Chemotherapy. 76(1). 91–100. 49 indexed citations

11.

Arca-Suárez, Jorge, Juan Carlos Vázquez-Ucha, Pablo A. Fraile-Ribot, et al.. (2020). Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection. Journal of Antimicrobial Chemotherapy. 75(11). 3209–3217. 35 indexed citations

12.

Gomis-Font, María A., Gabriel Cabot, Irina Sánchez-Diener, et al.. (2020). In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 75(9). 2508–2515. 37 indexed citations

13.

Moyá, Bartolomé, Isabel M. Barceló, Gabriel Cabot, et al.. (2019). In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 63(5). 40 indexed citations

14.

Sánchez-Diener, Irina, Laura Zamorano, Carmen Peña, et al.. (2019). Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections. Clinical Microbiology and Infection. 26(3). 351–357. 18 indexed citations

15.

Torrens, Gabriel, Gabriel Cabot, Carla López-Causapé, et al.. (2019). Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections. Frontiers in Microbiology. 10. 1868–1868. 14 indexed citations

16.

López-Causapé, Carla, Gabriel Cabot, Ester del Barrio-Tofiño, & Antonio Oliver. (2018). The Versatile Mutational Resistome of Pseudomonas aeruginosa. Frontiers in Microbiology. 9. 685–685. 174 indexed citations

17.

Torrens, Gabriel, Bartolomé Moyá, Laura Zamorano, et al.. (2017). Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system. PLoS ONE. 12(7). e0181932–e0181932. 30 indexed citations

18.

Gómez-Zorrilla, Sílvia, Carlos Juan, Gabriel Cabot, et al.. (2016). Impact of multidrug resistance on the pathogenicity of Pseudomonas aeruginosa: in vitro and in vivo studies. International Journal of Antimicrobial Agents. 47(5). 368–374. 33 indexed citations

19.

Rodríguez-Beltrán, Jerónimo, Gabriel Cabot, Coloma Costas, et al.. (2015). N-Acetylcysteine Selectively Antagonizes the Activity of Imipenem in Pseudomonas aeruginosa by an OprD-Mediated Mechanism. Antimicrobial Agents and Chemotherapy. 59(6). 3246–3251. 16 indexed citations

20.

Riera, Elena, Gabriel Cabot, Xavier Mulet, et al.. (2011). Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Journal of Antimicrobial Chemotherapy. 66(9). 2022–2027. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact